Jazz Pharmaceuticals Public Limited Company JAZZ
NASDAQ · United States · Health Technology
$232.73+1.21 (+0.52%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-03 | 5.71 | 6.18 | -7.5% | $1.21B | +8.4% | +3.5%$252.86→$261.62 |
| Q1 2026 | 2026-05-05 | 5.46 | 3.82 | +42.9% | — | — | +9.9%$208.06→$228.57 |
| Q4 2025 | 2026-02-24 | 6.64 | 6.51 | +2.0% | — | — | +13.6%$173.25→$196.83 |
| Q3 2025 | 2025-11-05 | 6.99 | 4.80 | +45.6% | — | — | -2.7%$137.82→$134.05 |
| Q4 2024 | 2025-02-25 | 6.60 | 5.81 | +13.6% | — | — | — |
| Q4 2023 | 2024-02-28 | 5.02 | 5.18 | -3.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.